This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Roy, S. Articles by Tenniswood, M. PubMed PubMed Citation Articles by Roy, S. Articles by Tenniswood, M.

Research Articles: Therapeutics, Targets, and Development

Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells

Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana

Requests for reprints: Martin Tenniswood, GEN*NY*SIS Center for Excellence in Cancer Genomics, Department of Biomedical Sciences, State University of New York at Albany, 1 Discovery Drive, Rensselaer, NY 12144. Phone: 518-591-7231; Fax: 518-591-7201. E-mail: mtenniswood{at}albany.edu

Abstract

Previous studies comparing the effects of two histone deacetylase (HDAC) inhibitors, trichostatin A (TSA) and CG-1521, have shown that these compounds selectively inhibit HDAC and induce differentially acetylated p53 isoforms and assembly of mutually exclusive transcriptional complexes on the p21 promoter. To determine whether the differential transcriptional regulation seen in p21 gene is unique or whether it is representative of the genome-wide effects of these two HDAC inhibitors, we have used microarray and Ingenuity pathway analysis to compare the effects of TSA and CG-1521 on gene expression on LNCaP cells. Gene array analysis confirmed by quantitative real-time PCR shows that CG-1521 modulates the expression of a highly circumscribed group of genes involved in cell cycle progression and cell death. In contrast, TSA appears to induce widespread transrepression of many genes and does not modulate the expression of the same cohort as CG-1521. These data show that the selective effects of CG-1521 and TSA on the assembly of transcription complexes are not unique to the p21 gene and suggest that selective inhibition of HDAC can lead to significant changes in gene expression through the acetylation of transcription factors including but not limited to p53. [Mol Cancer Ther 2008;7(7):1931–9]

Grant support: An unrestricted grant from the Coleman Foundation; Pat Girondi Fellowship in Molecular Medicine (S. Roy).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 11/30/07; revised 3/25/08; accepted 4/ 2/08.